Search

Your search keyword '"Lee, Yong Gu"' showing total 474 results

Search Constraints

Start Over You searched for: Author "Lee, Yong Gu" Remove constraint Author: "Lee, Yong Gu"
474 results on '"Lee, Yong Gu"'

Search Results

1. The BTLA–HVEM axis restricts CAR T cell efficacy in cancer

3. Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study

7. Development of Open Informal Dataset Affecting Autonomous Driving

13. Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy

18. Development of New Diffuse Large B Cell Lymphoma Mouse Models.

24. Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells

25. CD5 deletion enhances the antitumor activity of adoptive T cell therapies.

29. Streamlined measurement of chimeric antigen receptor T-cell concentration, size, viability and two-color phenotyping during manufacturing

31. The Role of Fibroblast Growth Factor-Binding Protein 1 in Skin Carcinogenesis and Inflammation

37. Abstract CT130: An open label, dose escalation, phase 1 study of AT101, a novel CD19-directed CAR-T cell therapy targeting a membrane-proximal epitope of CD19, in patients with relapsed or refractory B cell non-Hodgkin lymphoma

38. Data from Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer

39. Supplementary Figure from Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer

40. Figure S2 from Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction

41. Table S1 from Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction

42. Data from Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction

43. Apoptosis: aJanus bifronsin T-cell immunotherapy

49. Overcoming CD19-Negative Relapses in Patients with B-Cell Lymphomas Treated with Tisagenlecleucel

Catalog

Books, media, physical & digital resources